ARCHIVES

House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged.

This article is from The Cancer Letter archive.

Vol. 33 No. 13 | April 6, 2007

Download PDF Visit The Full Archive

Related Articles

Wistar Investigators Report Oncogene Relation to Burkitt’s

November 26, 1982

NCI’s New Policy On Costly Research

December 10, 1993

In Brief: Broder Resigns From IVX; Bishop To Receive Public Service Award; Johnston Rejoins NIAID

August 7, 1998

In Brief: Congress Working On Interim Financing Measure to Fund Agencies, Including NCI, Through Election

September 26, 1980

New SEER RFP Sees cheaper Way To Get Data

July 29, 1977

NCI Staff Finishes Center Program Study, Submits Recommendations

February 25, 1977